Alexza Pharmaceuticals Inc (ALXA)

0.94
0.01 1.63
Prev Close 0.92
Open 0.92
Day Low/High 0.91 / 0.95
52 Wk Low/High 0.22 / 1.60
Volume 305.73K
Avg Volume 144.20K
Exchange
Shares Outstanding 21.75M
Market Cap 20.01M
EPS -1.10
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Alexza Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Alexza Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Alexza...

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

Market News: Apple Inc, Vitae Pharmaceuticals, Alexza Pharmaceuticals

Market News: Apple Inc, Vitae Pharmaceuticals, Alexza Pharmaceuticals

Birinyi Associates president Laszlo Biriny opined that maybe the economy will catch up and the stock market may not have strong gains going forwardThe stock markets in the United States fluctuated on ...

Why to Buy These 5 Under-$10 Stocks ASAP

Why to Buy These 5 Under-$10 Stocks ASAP

Big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

7 Under-$10 Stocks Racing Higher

7 Under-$10 Stocks Racing Higher

If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

3 Biotech Stocks Under $10 to Trade for Breakouts

3 Biotech Stocks Under $10 to Trade for Breakouts

Keep these biotech stocks on your radar.

Top Insider Trades: AEGR VVTV CCO ALXA

Top Insider Trades: AEGR VVTV CCO ALXA

The top 10 open-market insider purchases and sales filed at the SEC Tuesday.

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stock lately.

13 Biotech Stock Predictions for 2013

13 Biotech Stock Predictions for 2013

TheStreet's Adam Feuerstein gazes into his crystal ball to offer his 2013 biotech stock forecast.

Stocks to Watch: Regions, Google, RIM

Stocks to Watch: Regions, Google, RIM

Regions Financial is being examined by federal agencies into allegations the bank improperly classified loans that went bad during the financial crisis, according to a report.

Shorting Alexza Pharma On FDA's Adasuve Approval

Shorting Alexza Pharma On FDA's Adasuve Approval

Alexza is setting up as a classic biotech run-down stock, says trader Mark Messier.

6 Stocks On Winning Streaks Short Sellers Do Not Believe In

6 Stocks On Winning Streaks Short Sellers Do Not Believe In

Short sellers make money when share price drops. To do this they borrow stock, sell the stock in the market, and [...]

Stocks Socked Despite Upbeat China Numbers; Apple Falls

Stocks Socked Despite Upbeat China Numbers; Apple Falls

Major U.S. stock fall Friday as upbeat economic data from China are offset by 'fiscal cliff' worries and a selloff in Apple shares.

The Next Big Thing in Biotech: FDA Decisions

The Next Big Thing in Biotech: FDA Decisions

Senior columnist Adam Feuerstein says three big FDA drug approval decisions are the next big things to watch in biotech.

Alexza Pharma: Premium Selling Options Strategy

Alexza Pharma: Premium Selling Options Strategy

A new options trade for Alexza going into an FDA drug approval decision.

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

Alexza expects US and European regulators to announce approval decisions in December.

21 Most Volatile Biopharma Stocks Closing Out 2012

21 Most Volatile Biopharma Stocks Closing Out 2012

These biopharma firms will be announcing FDA drug approval decisions and important clinical trial results.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look poised to break out and trade higher from current levels.

3 Health Care Stocks Under $10 Making Big Moves

3 Health Care Stocks Under $10 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

8 Stocks Under $10 Surging Higher

8 Stocks Under $10 Surging Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

Alexza Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Alexza Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Alexza Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

28 Drugs Facing FDA Approval in 2012-2013

28 Drugs Facing FDA Approval in 2012-2013

An updated calendar listing FDA drug approval decisions and advisory panels for the remainder of 2012 and early 2013

7 Stocks Under $10 With Relative Strength

7 Stocks Under $10 With Relative Strength

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Alexza Stock Gaps Down On Today's Open (ALXA)

Alexza Stock Gaps Down On Today's Open (ALXA)

Shares of Alexza Pharmaceuticals (Nasdaq:ALXA) were gapping down Wednesday morning with an open price 13.8% lower than Tuesday's closing price. The stock closed at $3.63 yesterday and opened today's trading at $3.13.

Friday's Top 10 Articles, Videos on TheStreet

Friday's Top 10 Articles, Videos on TheStreet

These stories made today's top 10 list of articles and videos on TheStreet.

Alexza Stock Gaps Down On Today's Open (ALXA)

Alexza Stock Gaps Down On Today's Open (ALXA)

Shares of Alexza Pharmaceuticals (Nasdaq:ALXA) were gapping down Friday morning with an open price 34.4% lower than Thursday's closing price. The stock closed at 61 cents yesterday and opened today's trading at 40 cents.